Data from by Pfizer/BioNTeh, Moderna for COVID-19 ワクチンs 'very 強健な'-EMA
BRUSSELS, Dec 10 (Reuters) - The data submitted to the European 薬／医学s 機関 (EMA) by Pfizer/BioNTech and Moderna for their COVID-19 ワクチン 候補者s is "very 強健な", its (n)役員／(a)執行力のある director said on Thursday.
"We have a data 始める，決める of over 30,000 支配するs who have been followed through the 臨床の 裁判，公判s. This gives us a very 強健な data 始める，決める on which to make a 決定／判定勝ち（する）, both on safety and efficacy," Emer Cooke said at a 委員会 会合 of the European 議会.
The 機関 is 推定する／予想するd to 完全にする reviews by Dec. 29 for the Pfizer/BioNTech ワクチン and Jan. 12 for the Moderna ワクチン at the 最新の.
"We cannot 保証（人） there will be a 肯定的な 結果," Cooke said.
(報告（する）／憶測ing by Francesco Guarascio; 令状ing by Matthias Blamont; Editing by Jon Boyle)
